Evaluation of Early Response to Neoadjuvant Chemotherapy with FDG PET/CT and MRI in Pediatric Patients with Bone Sarcoma

被引：0
|
作者：
Caglar, M. [1 ]
Aydin, B. [1 ]
Ergen, B. [1 ]
Karabulut, E. [1 ]
Akyuz, C. [1 ]
机构：
[1] Hacettepe Univ, Ankara, Turkey
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2015年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP495
引用
收藏
页码：S205 / S206
页数：2
相关论文
共 50 条
  • [21] Early decrements in bone density after completion of neoadjuvant chemotherapy in pediatric bone sarcoma patients
    Mueller, Carsten
    Winter, Corinna C.
    Rosenbaum, Dieter
    Boos, Joachim
    Gosheger, Georg
    Hardes, Jendrik
    Vieth, Volker
    BMC MUSCULOSKELETAL DISORDERS, 2010, 11
  • [22] MRI and 18F-FDG PET/CT in monitoring the response to neoadjuvant chemotherapy: is it necessary to appropriately select the patients?
    Evangelista, Laura
    Ruggieri, Domenico
    Pescarini, Luigi
    Saladini, Giorgio
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (08) : 1511 - 1514
  • [23] Early decrements in bone density after completion of neoadjuvant chemotherapy in pediatric bone sarcoma patients
    Carsten Müller
    Corinna C Winter
    Dieter Rosenbaum
    Joachim Boos
    Georg Gosheger
    Jendrik Hardes
    Volker Vieth
    BMC Musculoskeletal Disorders, 11
  • [24] MRI and 18F-FDG PET/CT in monitoring the response to neoadjuvant chemotherapy: is it necessary to appropriately select the patients?
    Laura Evangelista
    Domenico Ruggieri
    Luigi Pescarini
    Giorgio Saladini
    European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 1511 - 1514
  • [25] Evaluation of response to neoadjuvant chemotherapy in patients with extremity osteogenic sarcoma using F-18-FDG PET.
    Kim, YK
    Chung, JK
    So, Y
    Cheon, GJ
    Lee, DS
    Lee, SH
    Jeong, JM
    Lee, MC
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 258P - 258P
  • [26] Can FDG-PET/CT predict early response to neoadjuvant chemotherapy in breast cancer?
    Andrade, W. P.
    Lima, E. N. P.
    Osorio, C. A. B. T.
    do Socorro Maciel, M.
    Baiocchi, G.
    Bitencourt, A. G. V.
    Fanelli, M. F.
    Damascena, A. S.
    Soares, F. A.
    EJSO, 2013, 39 (12): : 1358 - 1363
  • [27] Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET
    Schulte, M
    Brecht-Krauss, D
    Werner, M
    Hartwig, E
    Sarkar, MR
    Keppler, P
    Kotzerke, J
    Guhlmann, A
    Delling, G
    Reske, SN
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (10) : 1637 - 1643
  • [28] FDG-PET/CT for response evaluation of invasive bladder cancer following neoadjuvant chemotherapy
    van de Putte, E. E. Fransen
    Vegt, E.
    Mertens, L. S.
    Bruining, A.
    Hendricksen, K.
    van der Heijden, M. S.
    Horenblas, S.
    van Rhijn, B. W. G.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2017, 49 (09) : 1585 - 1591
  • [29] FDG-PET/CT for response evaluation of invasive bladder cancer following neoadjuvant chemotherapy
    E. E. Fransen van de Putte
    E. Vegt
    L. S. Mertens
    A. Bruining
    K. Hendricksen
    M. S. van der Heijden
    S. Horenblas
    B. W. G. van Rhijn
    International Urology and Nephrology, 2017, 49 : 1585 - 1591
  • [30] Comparison of RECIST, EORTC criteria and PERCIST using MRI and PET/CT for evaluation of early response of neoadjuvant chemotherapy in patients with cervical carcinoma
    Sun, Yanqin
    Yu, Lijuan
    Nanding, Abiyasi
    Wang, Wenzhi
    Kuai, Zi-Xiang
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
12345